Burden Of Antimicrobial Resistance In US Healthcare Remains Substantial Amid Uneven Declines In Past Decade, Study Finds

Infectious Disease Advisor (6/4, Nye) reports a study found that the “rate of antimicrobial resistant (AMR)-related hospital admissions over the past decade varied by causative pathogen and rose for hospital-onset cases during the COVID-19 pandemic, highlighting the need for stronger AMR prevention strategies.” Researchers observed that “the rate of inpatient admissions due to AMR pathogens initially decreased from 209.6 in 2012 to 180.5 in 2016, increased to 189.2 in 2019, peaked at 197.0 in 2020, and then declined to 179.6 in 2022. A total of 6 pathogens represented 569,749 AMR-related hospitalizations in 2022, of which most (>75%) were due to community-onset disease.” In regard to hospital-onset AMR infections, “the incidence decreased from 48.6 in 2012 to 34.7 in 2016, increased to 42.7 in 2020, and then declined to 41.6 in 2022.” The study was published in JAMA Network Open.